Global Medical REIT (NYSE:GMRE) Rating Lowered to Sell at Wall Street Zen

Global Medical REIT (NYSE:GMREGet Free Report) was downgraded by analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research note issued on Thursday.

Several other research firms also recently weighed in on GMRE. Robert W. Baird decreased their price target on shares of Global Medical REIT from $10.00 to $9.00 and set a “neutral” rating on the stock in a research note on Thursday, May 8th. B. Riley assumed coverage on shares of Global Medical REIT in a report on Thursday, April 3rd. They issued a “neutral” rating and a $9.00 price objective for the company. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average target price of $10.44.

Read Our Latest Research Report on GMRE

Global Medical REIT Stock Performance

NYSE GMRE opened at $6.21 on Thursday. The company has a debt-to-equity ratio of 1.26, a current ratio of 0.28 and a quick ratio of 0.28. The stock’s 50 day simple moving average is $7.56 and its 200-day simple moving average is $8.05. The company has a market cap of $415.47 million, a PE ratio of -310.49, a price-to-earnings-growth ratio of 1.43 and a beta of 1.23. Global Medical REIT has a 1-year low of $6.06 and a 1-year high of $10.46.

Global Medical REIT (NYSE:GMREGet Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The company reported $0.22 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.22. Global Medical REIT had a return on equity of 0.86% and a net margin of 3.23%. The company had revenue of $34.60 million for the quarter, compared to analyst estimates of $35.49 million. As a group, equities research analysts anticipate that Global Medical REIT will post 0.81 EPS for the current fiscal year.

Institutional Investors Weigh In On Global Medical REIT

A number of hedge funds have recently modified their holdings of GMRE. Quarry LP boosted its holdings in Global Medical REIT by 111.5% in the 4th quarter. Quarry LP now owns 4,940 shares of the company’s stock valued at $38,000 after purchasing an additional 2,604 shares during the last quarter. PNC Financial Services Group Inc. lifted its holdings in Global Medical REIT by 58.1% in the fourth quarter. PNC Financial Services Group Inc. now owns 6,260 shares of the company’s stock valued at $48,000 after acquiring an additional 2,301 shares during the last quarter. GAMMA Investing LLC lifted its holdings in Global Medical REIT by 11,234.4% in the first quarter. GAMMA Investing LLC now owns 7,254 shares of the company’s stock valued at $63,000 after acquiring an additional 7,190 shares during the last quarter. State of Wyoming purchased a new position in Global Medical REIT in the first quarter worth approximately $65,000. Finally, Squarepoint Ops LLC acquired a new stake in Global Medical REIT during the fourth quarter worth $82,000. Hedge funds and other institutional investors own 57.52% of the company’s stock.

About Global Medical REIT

(Get Free Report)

Global Medical REIT Inc (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.

Further Reading

Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.